You are using an older browser version. Please use a supported version for the best MSN experience.

ZOSANO PHARMA CORPORATION

NASDAQ: ZSAN
1.17
+0.12
+11.43%
  • Key statistics
  • Growth
  • Profitability
  • Price ratios
Industry Biotechnology & Medical Research
Highlights
Analyst Recommendation: Strong Buy
    • Revenue

    • 0

    • Net Income

    • -37.59M

    • Market Cap.

    • 54.36M

    • Enterprise Value

    • 48.35M

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 2.90

    • Forward P/E

    • -1.76

    • Price/Sales

    • 0.00

    • Price/Book Value

    • 2.63

    • Price/Cash flow

    • -

      • EBITDA

      • -36.50M

      • Return on Capital %

      • -81.12

      • Return on Equity %

      • -219.22

      • Return on Assets %

      • -81.12

      • Book Value/Share

      • 0.44

      • Shares Outstanding

      • 54.36M

      • Last Split Factor (Date)

      • 1:20 (1/26/2018)

      • Last Dividend (Ex-Date)

      • 0.00 (-)

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      8/4/2020
      Strong Buy
        • 1 Year Price Target

        • 4.00

        • Analysts

        • 1

        • EPS Estimate

        • -0.64

        • Cashflow Estimate

        • -

        Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

        • Sales (Revenue)

          Q/Q (Last Year)

        • -

        • 13.70

        • Net Income

          YTD/YTD (Last Year)

        • -6.31

        • -24.91

        • Net Income

          Q/Q (Last Year)

        • 7.82

        • -29.36

        • Sales (Revenue)

          5-Year Annual Average

        • -

        • -

        • Net Income

          5-Year Annual Average

        • -

        • -

        • Dividends

          5-Year Annual Average

        • -

        • -

        • Profit Margins (%)

        • Company

        • Industry

        • Gross Margin

        • -

        • 61.48

        • Pre-Tax Margin

        • -

        • -18.54

        • Net Profit Margin

        • -

        • -14.30

        • Average Gross Margin

          5-Year Annual Average

        • -

        • 63.90

        • Average Pre-Tax Margin

          5-Year Annual Average

        • -51,217.57

        • 0.26

        • Average Net Profit Margin

          5-Year Annual Average

        • -51,217.57

        • -3.9

        • Price Ratios

        • Company

        • Industry

        • Current P/E Ratio

        • -

        • -

        • P/E Ratio 5-Year High

        • -

        • -

        • P/E Ratio 5-Year Low

        • -

        • -

        • Price/Sales Ratio

        • -

        • 9.67

        • Price/Book Value

        • 2.63

        • 6.67

        • Price/Cash Flow Ratio

        • -

        • 28.72

        Current Historical
        • Financial health
        • Trading statistics
        • Management effectiveness
        Industry Biotechnology & Medical Research
        • Financial Ratios

        • Company

        • Industry

        • Debt/Equity Ratio

        • 0.21

        • 0.45

        • Current Ratio

        • 0.93

        • 3.44

        • Quick Ratio

        • -

        • 3.03

        • Leverage Ratio

        • 2.31

        • 1.94

        • Book Value/Share

        • 0.44

        • 1.88

        • Key Metrics

        • Company

          • Shares Short

            as of -

          • -

          • Short Ratio

            as of -

          • -

          • Short % of Float

            as of -

          • -

          • Shares Short

            prior month

          • -

          • Trailing Annual Dividend Yield

          • -

          • 5 Year Average Dividend Yield

          • 0.00

          • Key Metrics

          • Company

            • Payout Ratio

            • -

            • Dividend Date

            • -

            • Ex-Dividend Date

            • -

            • Last Split Factor

              new per old

            • 1:20

            • Last Split Date

            • 1/26/2018

            • Key Metrics

            • Company

            • Industry

            • Return on Equity %

              (5-Year Average)

            • -219.22

              (-292.86)

            • -14.22

              (-3.09)

            • Return on Assets %

              (5-Year Average)

            • -81.12

              (-110.16)

            • -6.74

              (-1.28)

            • Return on Capital %

              (5-Year Average)

            • -133.79

              (-173.70)

            • -8.64

              (-1.54)

            • Income/Employee

            • -689.71k

            • -124.24k

            • Inventory Turnover

            • -

            • 2.93

            • Asset Turnover

            • 0.00

            • 0.38

            Current Historical
            AdChoices
            AdChoices
            AdChoices
            image beaconimage beaconimage beacon